SLXN

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

About Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Details

Daily high
$2.65
Daily low
$2.48
Price at open
$2.65
52 Week High
$51.75
52 Week Low
$2.13
Market cap
8.1M
Dividend yield
0.00%
Volume
22,714
Avg. volume
60,158
P/E ratio
-.10

Silexion Therapeutics Corp - Ordinary Shares News

Details

Daily high
$2.65
Daily low
$2.48
Price at open
$2.65
52 Week High
$51.75
52 Week Low
$2.13
Market cap
8.1M
Dividend yield
0.00%
Volume
22,714
Avg. volume
60,158
P/E ratio
-.10